{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:09:28Z","timestamp":1792516168655,"version":"4.5.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s12350-020-02280-4","type":"journal-article","created":{"date-parts":[[2020,8,20]],"date-time":"2020-08-20T20:14:02Z","timestamp":1597954442000},"page":"510-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Coronary artery disease in patients with human immunodeficiency virus infection"],"prefix":"10.1016","volume":"28","author":[{"given":"Pratik","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aljizeeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Harikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquita S.","family":"Affandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny R.","family":"Buechel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouaz H.","family":"Al-Mallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diwakar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s12350-020-02280-4_bib1","unstructured":"WHO | 10 facts on HIV\/AIDS. https:\/\/www.who.int\/features\/factfiles\/hiv\/facts\/en\/index3.html."},{"key":"10.1007\/s12350-020-02280-4_bib2","unstructured":"United States of America. http:\/\/www.unaids.org\/en\/regionscountries\/countries\/unitedstatesofamerica."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.acvd.2015.01.004","article-title":"Epidemiology of coronary heart disease in HIV-infected versus uninfected individuals in developed countries","volume":"108","author":"Lang","year":"2015","journal-title":"Arch Cardiovasc Dis."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib4","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0956462416632428","article-title":"Prevalence and distribution of non-AIDS causes of death among HIV-infected individuals receiving antiretroviral therapy: A systematic review and meta-analysis","volume":"28","author":"Farahani","year":"2017","journal-title":"Int J STD AIDS."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib5","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/01.aids.0000166097.46940.35","article-title":"Change in atherosclerosis progression in HIV-infected patients: ANRS Aquitaine Cohort, 1999-2004","volume":"19","author":"Thi\u00e9baut","year":"2005","journal-title":"AIDS Lond Engl."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib6","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1468-1293.2005.00324.x","article-title":"Carotid intima-media thickness is slightly increased over time in HIV-1-infected patients","volume":"6","author":"Merci\u00e9","year":"2005","journal-title":"HIV Med."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1086\/527564","article-title":"High prevalence of peripheral arterial disease in HIV-infected persons","volume":"46","author":"Periard","year":"2008","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"key":"10.1007\/s12350-020-02280-4_bib8","first-page":"135","article-title":"Lipodystrophy in HIV patients: Its challenges and management approaches","volume":"3","author":"Singhania","year":"2011","journal-title":"HIV AIDS (Auckl)."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/COH.0b013e3282f6a613","article-title":"Conventional cardiovascular risk factors in HIV infection: How conventional are they?","volume":"3","author":"Sabin","year":"2008","journal-title":"Curr Opin HIV AIDS."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib10","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1161\/ATVBAHA.113.302191","article-title":"HIV, inflammation, and calcium in atherosclerosis","volume":"34","author":"Shrestha","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1007\/s12350-020-02280-4_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/693083","article-title":"Diverse roles of macrophages in atherosclerosis: From inflammatory biology to biomarker discovery","volume":"2012","author":"Gui","year":"2012","journal-title":"Mediators Inflamm."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/82763","article-title":"IL-6 switches the differentiation of monocytes from dendritic cells to macrophages","volume":"1","author":"Chomarat","year":"2000","journal-title":"Nat Immunol."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: Pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol Rev."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1464-2662.2001.00096.x","article-title":"Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART","volume":"3","author":"Stone","year":"2002","journal-title":"HIV Med."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib15","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med."},{"issue":"16","key":"10.1007\/s12350-020-02280-4_bib16","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib17","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: From AIDS to atherosclerosis","volume":"162","author":"Jones","year":"2011","journal-title":"Br J Pharmacol."},{"issue":"5283","key":"10.1007\/s12350-020-02280-4_bib18","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","volume":"273","author":"Dean","year":"1996","journal-title":"Science."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCRESAHA.107.151860b","article-title":"Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall","volume":"101","author":"Rao","year":"2007","journal-title":"Circ Res."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib20","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1046\/j.1365-2249.1999.01081.x","article-title":"Adhesion molecules (E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1)) in sera from patients with Staphylococcus aureus bacteraemia with or without endocarditis","volume":"118","author":"S\u00f6derquist","year":"1999","journal-title":"Clin Exp Immunol."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1189\/jlb.0809580","article-title":"The macrophage: The intersection between HIV infection and atherosclerosis","volume":"87","author":"Crowe","year":"2010","journal-title":"J Leukoc Biol."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib22","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1161\/ATVBAHA.110.221127","article-title":"Monocyte and macrophage dynamics during atherogenesis","volume":"31","author":"Ley","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib23","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/12433","article-title":"HIV-1 Nef mediates lymphocyte chemotaxis and activation by infected macrophages","volume":"5","author":"Swingler","year":"1999","journal-title":"Nat Med."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1172\/JCI200316261","article-title":"HIV protease inhibitors promote atherosclerotic lesion formation independent of dyslipidemia by increasing CD36-dependent cholesteryl ester accumulation in macrophages","volume":"111","author":"Dressman","year":"2003","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.atherosclerosis.2007.10.007","article-title":"Infection and inflammation decrease apolipoprotein M expression","volume":"199","author":"Feingold","year":"2008","journal-title":"Atherosclerosis."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib26","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/CIRCRESAHA.110.224766","article-title":"The role of endoplasmic reticulum stress in the progression of atherosclerosis","volume":"107","author":"Tabas","year":"2010","journal-title":"Circ Res."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib27","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.cdd.4401373","article-title":"Roles of CHOP\/GADD153 in endoplasmic reticulum stress","volume":"11","author":"Oyadomari","year":"2004","journal-title":"Cell Death Differ."},{"issue":"Suppl 1","key":"10.1007\/s12350-020-02280-4_bib28","first-page":"E40","article-title":"Macrophage apoptosis in advanced atherosclerosis","volume":"1173","author":"Tabas","year":"2009","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/emboj.2010.284","article-title":"Interaction of calmodulin with Sec61\u03b1 limits Ca2+ leakage from the endoplasmic reticulum","volume":"30","author":"Erdmann","year":"2011","journal-title":"EMBO J."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib30","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a004317","article-title":"Endoplasmic-reticulum calcium depletion and disease","volume":"3","author":"Mekahli","year":"2011","journal-title":"Cold Spring Harb Perspect Biol."},{"issue":"49","key":"10.1007\/s12350-020-02280-4_bib31","doi-asserted-by":"crossref","first-page":"34765","DOI":"10.1074\/jbc.274.49.34765","article-title":"The HIV Nef protein alters Ca(2+) signaling in myelomonocytic cells through SH3-mediated protein-protein interactions","volume":"274","author":"Foti","year":"1999","journal-title":"J Biol Chem."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib32","doi-asserted-by":"crossref","first-page":"e3731","DOI":"10.1371\/journal.pone.0003731","article-title":"HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization","volume":"3","author":"Norman","year":"2008","journal-title":"PLoS ONE."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib33","doi-asserted-by":"crossref","first-page":"837","DOI":"10.7326\/0003-4819-129-10-199811150-00022","article-title":"Impaired glucose tolerance and protease inhibitors","volume":"129","author":"Walli","year":"1998","journal-title":"Ann Intern Med."},{"issue":"9170","key":"10.1007\/s12350-020-02280-4_bib34","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet Lond Engl."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib35","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1345\/aph.19231","article-title":"Hyperglycemia associated with protease inhibitors in an urban HIV-infected minority patient population","volume":"34","author":"Dever","year":"2000","journal-title":"Ann Pharmacother."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib36","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1161\/CIRCULATIONAHA.107.189623","article-title":"Contribution of metabolic and anthropometric abnormalities to cardiovascular disease risk factors","volume":"118","author":"Grunfeld","year":"2008","journal-title":"Circulation."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1177\/135965350501000511","article-title":"Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study","volume":"10","author":"Young","year":"2005","journal-title":"Antivir Ther."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib38","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ramb.2012.11.003","article-title":"Lipid profile of HIV-infected patients in relation to antiretroviral therapy: A review","volume":"59","author":"Souza","year":"2013","journal-title":"Rev Assoc Medica Bras"},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/cid\/ciu261","article-title":"Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients","volume":"59","author":"Ingle","year":"2014","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/QAI.0000000000000419","article-title":"HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction","volume":"68","author":"Paisible","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/QAI.0000000000000009","article-title":"Immunodeficiency and risk of myocardial infarction among HIV-positive individuals with access to care","volume":"65","author":"Silverberg","year":"2014","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib42","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/QAI.0b013e31821d33a5","article-title":"Association between HIV infection, antiretroviral therapy, and risk of acute myocardial infarction: A cohort and nested case-control study using Qu\u00e9bec\u2019s public health insurance database","volume":"57","author":"Durand","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1097\/QAD.0b013e328339192f","article-title":"Increased risk of myocardial infarction in HIV-infected patients in France, relative to the general population","volume":"24","author":"Lang","year":"2010","journal-title":"AIDS Lond Engl."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1468-1293.2005.00265.x","article-title":"Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients","volume":"6","author":"Iloeje","year":"2005","journal-title":"HIV Med."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib45","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1089\/088922203766774487","article-title":"Incidence of myocardial infarction in randomized clinical trials of protease inhibitor-based antiretroviral therapy: An analysis of four different protease inhibitors","volume":"19","author":"Coplan","year":"2003","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"21","key":"10.1007\/s12350-020-02280-4_bib46","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/00126334-200308010-00012","article-title":"Coronary heart disease in HIV-infected individuals","volume":"33","author":"Currier","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib48","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJMoa022048","article-title":"Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection","volume":"348","author":"Bozzette","year":"2003","journal-title":"N Engl J Med."},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib49","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1093\/cid\/civ014","article-title":"Declining relative risk for myocardial infarction among HIV-positive compared with HIV-negative individuals with access to care","volume":"60","author":"Klein","year":"2015","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib50","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.amjcard.2012.05.045","article-title":"Comparison of in-hospital mortality from acute myocardial infarction in HIV sero-positive versus sero-negative individuals","volume":"110","author":"Pearce","year":"2012","journal-title":"Am J Cardiol."},{"issue":"21","key":"10.1007\/s12350-020-02280-4_bib51","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1016\/j.jacc.2012.02.024","article-title":"Sudden cardiac death in patients with human immunodeficiency virus infection","volume":"59","author":"Tseng","year":"2012","journal-title":"J Am Coll Cardiol."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib52","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"Triant","year":"2007","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/jamainternmed.2013.3728","article-title":"HIV infection and the risk of acute myocardial infarction","volume":"173","author":"Freiberg","year":"2013","journal-title":"JAMA Intern Med."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib54","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2105\/AJPH.2009.188664","article-title":"Smoking-related health risks among persons with HIV in the strategies for management of antiretroviral therapy clinical trial","volume":"100","author":"Lifson","year":"2010","journal-title":"Am J Public Health."},{"issue":"17","key":"10.1007\/s12350-020-02280-4_bib55","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","article-title":"Class of antiretroviral drugs and the risk of myocardial infarction","volume":"356","author":"Friis-M\u00f8ller","year":"2007","journal-title":"N Engl J Med."},{"issue":"22","key":"10.1007\/s12350-020-02280-4_bib56","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib57","doi-asserted-by":"crossref","first-page":"289","DOI":"10.7326\/0003-4819-149-5-200809020-00003","article-title":"Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: A randomized trial","volume":"149","author":"El-Sadr","year":"2008","journal-title":"Ann Intern Med."},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib58","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1093\/infdis\/jis502","article-title":"Modest nonadherence to antiretroviral therapy promotes residual HIV-1 replication in the absence of virological rebound in plasma","volume":"206","author":"Pasternak","year":"2012","journal-title":"J Infect Dis."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/jvh.12447","article-title":"Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients","volume":"23","author":"Fern\u00e1ndez-Montero","year":"2016","journal-title":"J Viral Hepat."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib60","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1536\/ihj.46.205","article-title":"Are the high levels of cytomegalovirus antibodies a determinant in the development of coronary artery disease?","volume":"46","author":"Eryol","year":"2005","journal-title":"Int Heart J."},{"issue":"13","key":"10.1007\/s12350-020-02280-4_bib61","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1001\/archinte.160.13.2027","article-title":"A prospective study of cytomegalovirus, herpes simplex virus 1, and coronary heart disease: The atherosclerosis risk in communities (ARIC) study","volume":"160","author":"Sorlie","year":"2000","journal-title":"Arch Intern Med."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib62","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1055\/s-0038-1656027","article-title":"Soluble adhesion molecules and endothelial cell damage in HIV infected patients","volume":"77","author":"Seigneur","year":"1997","journal-title":"Thromb Haemost."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib63","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacc.2012.06.063","article-title":"HIV and coronary heart disease: Time for a better understanding","volume":"61","author":"Boccara","year":"2013","journal-title":"J Am Coll Cardiol."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib64","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0b013e32833ad914","article-title":"Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection","volume":"24","author":"Ford","year":"2010","journal-title":"AIDS Lond Engl."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib65","first-page":"208","article-title":"Plasma hypercoagulability is correlated to plasma HIV load","volume":"80","author":"Karmochkine","year":"1998","journal-title":"Thromb Haemost."},{"issue":"13","key":"10.1007\/s12350-020-02280-4_bib66","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med."},{"issue":"9156","key":"10.1007\/s12350-020-02280-4_bib67","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(99)01122-8","article-title":"Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: A prospective cohort study. Swiss HIV Cohort Study","volume":"353","author":"Ledergerber","year":"1999","journal-title":"Lancet Lond Engl."},{"issue":"9142","key":"10.1007\/s12350-020-02280-4_bib68","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(98)03201-2","article-title":"Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group","volume":"352","author":"Mocroft","year":"1998","journal-title":"Lancet Lond Engl."},{"issue":"12","key":"10.1007\/s12350-020-02280-4_bib69","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib70","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1046\/j.1468-1293.2003.00159.x","article-title":"HIV lipodystrophy: Prevalence, severity and correlates of risk in Australia","volume":"4","author":"Miller","year":"2003","journal-title":"HIV Med."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00001432-200402000-00005","article-title":"What is HIV-associated lipodystrophy? Defining fat distribution changes in HIV infection","volume":"17","author":"Tien","year":"2004","journal-title":"Curr Opin Infect Dis."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib72","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200107010-00004","article-title":"Stavudine versus zidovudine and the development of lipodystrophy","volume":"27","author":"Bogner","year":"2001","journal-title":"J Acquir Immune Defic Syndr."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib73","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.qai.0000224974.67962.ce","article-title":"Tissue-specific associations between mitochondrial DNA levels and current treatment status in HIV-infected individuals","volume":"42","author":"Cherry","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"16","key":"10.1007\/s12350-020-02280-4_bib74","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1097\/01.aids.0000183629.20041.bb","article-title":"Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides","volume":"19","author":"Dub\u00e9","year":"2005","journal-title":"AIDS Lond Engl."},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib75","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/QAD.0b013e32832b4377","article-title":"Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment","volume":"23","author":"Haubrich","year":"2009","journal-title":"AIDS Lond Engl."},{"issue":"16","key":"10.1007\/s12350-020-02280-4_bib76","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1097\/01.aids.0000247574.33998.03","article-title":"A randomized comparative trial of tenofovir DF or abacavir as replacement for a thymidine analogue in persons with lipoatrophy","volume":"20","author":"Moyle","year":"2006","journal-title":"AIDS Lond Engl."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib77","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: The results of the TARHEEL study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib78","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: The MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS Lond Engl."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1468-1293.2008.00512.x","article-title":"Patterns and predictors of the use of different antiretroviral drug regimens at treatment initiation in the UK","volume":"9","author":"Easterbrook","year":"2008","journal-title":"HIV Med."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib80","doi-asserted-by":"crossref","first-page":"E332","DOI":"10.1152\/ajpendo.00058.2002","article-title":"Metabolic basis of HIV-lipodystrophy syndrome","volume":"283","author":"Sekhar","year":"2002","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib81","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-004-1508-2","article-title":"In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing\u2019s syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue","volume":"47","author":"Sutinen","year":"2004","journal-title":"Diabetologia."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/QAI.0b013e3181cbdaff","article-title":"Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: A randomized placebo-controlled trial with a safety extension","volume":"53","author":"Falutz","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib83","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1210\/jc.2010-0490","volume":"95","author":"Falutz","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib84","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1468-1293.2005.00328.x","article-title":"The effect of low-dose ritonavir monotherapy on fasting serum lipid concentrations","volume":"6","author":"Shafran","year":"2005","journal-title":"HIV Med."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib85","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00002030-200403050-00008","article-title":"The metabolic effects of lopinavir\/ritonavir in HIV-negative men","volume":"18","author":"Lee","year":"2004","journal-title":"AIDS Lond Engl."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib86","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/QAI.0b013e318031d5a0","article-title":"Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095)","volume":"44","author":"Shikuma","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib87","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1371\/journal.pmed.0010019","article-title":"Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1","volume":"1","author":"van Leth","year":"2004","journal-title":"PLoS Med."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib88","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0b013e32833ad8b4","article-title":"A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206","volume":"24","author":"Tungsiripat","year":"2010","journal-title":"AIDS Lond Engl."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib89","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1056\/NEJM199908123410707","article-title":"Drug treatment of lipid disorders","volume":"341","author":"Knopp","year":"1999","journal-title":"N Engl J Med."},{"issue":"13","key":"10.1007\/s12350-020-02280-4_bib90","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJM200103293441307","article-title":"Interactions among drugs for HIV and opportunistic infections","volume":"344","author":"Piscitelli","year":"2001","journal-title":"N Engl J Med."},{"issue":"1B","key":"10.1007\/s12350-020-02280-4_bib91","doi-asserted-by":"crossref","first-page":"25S","DOI":"10.1016\/0002-9343(91)90053-Z","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin","volume":"91","author":"Dujovne","year":"1991","journal-title":"Am J Med."},{"issue":"15","key":"10.1007\/s12350-020-02280-4_bib92","doi-asserted-by":"crossref","first-page":"28J","DOI":"10.1016\/0002-9149(88)90004-5","article-title":"Efficacy and long-term adverse effect pattern of lovastatin","volume":"62","author":"Tobert","year":"1988","journal-title":"Am J Cardiol."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib93","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1001\/archinte.165.10.1179","article-title":"Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study","volume":"165","author":"Brown","year":"2005","journal-title":"Arch Intern Med."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib94","first-page":"89","article-title":"Insulin resistance in HIV infection: Drugs, host responses, or restoration to health?","volume":"16","author":"Grunfeld","year":"2008","journal-title":"Top HIV Med Publ Int AIDS Soc USA"},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib95","doi-asserted-by":"crossref","first-page":"E1666","DOI":"10.1152\/ajpendo.00550.2006","article-title":"Effects of a nucleoside reverse transcriptase inhibitor, stavudine, on glucose disposal and mitochondrial function in muscle of healthy adults","volume":"292","author":"Fleischman","year":"2007","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"12","key":"10.1007\/s12350-020-02280-4_bib96","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1089\/aid.2006.22.1242","article-title":"Inappropriately low glycated hemoglobin values and hemolysis in HIV-infected patients","volume":"22","author":"Diop","year":"2006","journal-title":"AIDS Res Hum Retroviruses."},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib97","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/dc09-0177","article-title":"A1C underestimates glycemia in HIV infection","volume":"32","author":"Kim","year":"2009","journal-title":"Diabetes Care."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib98","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.CIR.0000114520.38748.AA","article-title":"Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection","volume":"109","author":"Hsue","year":"2004","journal-title":"Circulation."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib99","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1093\/eurheartj\/ehr456","article-title":"Acute coronary syndromes in human immunodeficiency virus patients: A meta-analysis investigating adverse event rates and the role of antiretroviral therapy","volume":"33","author":"D\u2019Ascenzo","year":"2012","journal-title":"Eur Heart J."},{"issue":"12","key":"10.1007\/s12350-020-02280-4_bib100","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCRESAHA.114.302721","article-title":"Mechanisms of plaque formation and rupture","volume":"114","author":"Bentzon","year":"2014","journal-title":"Circ Res."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib101","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOL.0000000000000440","article-title":"Mechanisms of erosion of atherosclerotic plaques","volume":"28","author":"Quillard","year":"2017","journal-title":"Curr Opin Lipidol."},{"key":"10.1007\/s12350-020-02280-4_bib102","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fimmu.2017.00081","article-title":"Neutrophil extracellular traps and its implications in inflammation: An overview","volume":"8","author":"Delgado-Rizo","year":"2017","journal-title":"Front Immunol."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib103","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCRESAHA.117.310694","article-title":"Flow perturbation mediates neutrophil recruitment and potentiates endothelial injury via TLR2 in mice: Implications for superficial erosion","volume":"121","author":"Franck","year":"2017","journal-title":"Circ Res."},{"issue":"22","key":"10.1007\/s12350-020-02280-4_bib104","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1093\/eurheartj\/ehv044","article-title":"TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: Implications for superficial erosion","volume":"36","author":"Quillard","year":"2015","journal-title":"Eur Heart J."},{"key":"10.1007\/s12350-020-02280-4_bib105","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2018.05.001","article-title":"Evaluation of coronary features of HIV patients presenting with ACS: The CUORE, a multicenter study","volume":"274","author":"Peyracchia","year":"2018","journal-title":"Atherosclerosis."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib106","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.thromres.2014.05.037","article-title":"Prognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: Use of registry data from 12 sites in Europe, South Africa and the United States","volume":"134","author":"D\u2019Ascenzo","year":"2014","journal-title":"Thromb Res."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib107","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/eurheartj\/ehq372","article-title":"Acute coronary syndrome in human immunodeficiency virus-infected patients: Characteristics and 1 year prognosis","volume":"32","author":"Boccara","year":"2011","journal-title":"Eur Heart J."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib108","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1001\/jamacardio.2016.5139","article-title":"Types of myocardial infarction among human immunodeficiency virus-infected individuals in the United States","volume":"2","author":"Crane","year":"2017","journal-title":"JAMA Cardiol."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib109","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.amjcard.2009.03.036","article-title":"Comparison of outcomes using bare metal versus drug-eluting stents in coronary artery disease patients with and without human immunodeficiency virus infection","volume":"104","author":"Ren","year":"2009","journal-title":"Am J Cardiol."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/157016208783571900","article-title":"Coronary artery bypass graft in HIV-infected patients: A multicenter case control study","volume":"6","author":"Boccara","year":"2008","journal-title":"Curr HIV Res."},{"key":"10.1007\/s12350-020-02280-4_bib111","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijcard.2017.02.117","article-title":"Cardiovascular disease in women with HIV-1 infection","volume":"241","author":"Volpe","year":"2017","journal-title":"Int J Cardiol."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib112","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1161\/JAHA.114.001035","article-title":"HIV infection and cardiovascular disease in women","volume":"3","author":"Womack","year":"2014","journal-title":"J Am Heart Assoc."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib113","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/infdis\/jit508","article-title":"Noncalcified coronary atherosclerotic plaque and immune activation in HIV-infected women","volume":"208","author":"Fitch","year":"2013","journal-title":"J Infect Dis."},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib114","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0735-1097(02)02164-2","article-title":"ACC\/AHA 2002 guideline update for exercise testing: Summary article. A report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines)","volume":"40","author":"Gibbons","year":"2002","journal-title":"J Am Coll Cardiol."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib115","doi-asserted-by":"crossref","first-page":"552","DOI":"10.7326\/0003-4819-132-7-200004040-00007","article-title":"Heart rate recovery after submaximal exercise testing as a predictor of mortality in a cardiovascularly healthy cohort","volume":"132","author":"Cole","year":"2000","journal-title":"Ann Intern Med."},{"issue":"22","key":"10.1007\/s12350-020-02280-4_bib116","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1161\/01.CIR.0000039329.47437.3B","article-title":"Role of nondiagnostic exercise-induced ST-segment abnormalities in predicting future coronary events in asymptomatic volunteers","volume":"106","author":"Rywik","year":"2002","journal-title":"Circulation."},{"issue":"9","key":"10.1007\/s12350-020-02280-4_bib117","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1056\/NEJM200003023420915","article-title":"Recovery of heart rate after exercise","volume":"342","author":"Jouven","year":"2000","journal-title":"N Engl J Med."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib118","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1086\/338398","article-title":"Exercise stress testing for detection of silent myocardial ischemia in human immunodeficiency virus-infected patients receiving antiretroviral therapy","volume":"34","author":"Duong","year":"2002","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am."},{"issue":"Suppl 1","key":"10.1007\/s12350-020-02280-4_bib119","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10554-008-9414-1","article-title":"Strain imaging in echocardiography: Methods and clinical applications","volume":"25","author":"Nesbitt","year":"2009","journal-title":"Int J Cardiovasc Imaging."},{"issue":"21","key":"10.1007\/s12350-020-02280-4_bib120","first-page":"1673","article-title":"Prognostic implications of global LV dysfunction: A systematic review and meta-analysis of global longitudinal strain and ejection fraction","volume":"100","author":"Kalam","year":"2014","journal-title":"Heart Br Card Soc."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib121","first-page":"975","article-title":"Myocardial deformation imaging unmasks subtle left ventricular systolic dysfunction in asymptomatic and treatment-na\u00efve HIV patients","volume":"104","author":"Karavidas","year":"2015","journal-title":"Clin Res Cardiol Off J Ger Card Soc."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib122","first-page":"321","article-title":"Evaluation of subtle left ventricular systolic dysfunction by longitudinal systolic strain in patients with human immunodeficiency virus","volume":"34","author":"Cetin","year":"2018","journal-title":"Acta Cardiol Sin."},{"issue":"20","key":"10.1007\/s12350-020-02280-4_bib123","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/j.jacc.2007.07.061","article-title":"Role of right ventricular wall motion abnormalities in risk stratification and prognosis of patients referred for stress echocardiography","volume":"50","author":"Bangalore","year":"2007","journal-title":"J Am Coll Cardiol."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib124","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.echo.2006.08.014","article-title":"Risk stratification using stress echocardiography: Incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease","volume":"20","author":"Bangalore","year":"2007","journal-title":"J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib125","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjcard.2004.06.002","article-title":"Novel stress echocardiographic model incorporating the extent and severity of wall motion abnormality for risk stratification and prognosis","volume":"94","author":"Yao","year":"2004","journal-title":"Am J Cardiol."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/CIRCIMAGING.110.961060","article-title":"Risk stratification and prognosis of human immunodeficiency virus-infected patients with known or suspected coronary artery disease referred for stress echocardiography","volume":"4","author":"Wever Pinzon","year":"2011","journal-title":"Circ Cardiovasc Imaging."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib127","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/QAD.0b013e3282f20a77","article-title":"Asymptomatic myocardial ischaemia in HIV-infected adults","volume":"22","author":"Carr","year":"2008","journal-title":"AIDS Lond Engl."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib128","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jinf.2011.09.007","article-title":"Significant coronary stenosis detected by coronary computed angiography in asymptomatic HIV infected subjects","volume":"64","author":"d\u2019Ettorre","year":"2012","journal-title":"J Infect."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib129","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/QAD.0b013e328333ea9e","article-title":"Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men","volume":"24","author":"Lo","year":"2010","journal-title":"AIDS Lond Engl."},{"issue":"10","key":"10.1007\/s12350-020-02280-4_bib130","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1089\/apc.2009.0048","article-title":"Long-term combination antiretroviral therapy is associated with the risk of coronary plaques in African Americans with HIV infection","volume":"23","author":"Lai","year":"2009","journal-title":"AIDS Patient Care STDs."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib131","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/00042560-200206010-00008","article-title":"Electron beam computed tomography for assessment of coronary artery disease in HIV-infected men receiving antiretroviral therapy","volume":"30","author":"Talwani","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"18","key":"10.1007\/s12350-020-02280-4_bib132","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2012.07.038","article-title":"Does rubidium-82 PET have superior accuracy to SPECT perfusion imaging for the diagnosis of obstructive coronary disease? A systematic review and meta-analysis","volume":"60","author":"Mc Ardle","year":"2012","journal-title":"J Am Coll Cardiol."},{"key":"10.1007\/s12350-020-02280-4_bib133","unstructured":"Jain D, Zaret BL: Chapter: Nuclear Cardiology: In Essential Cardiology: Principles and Practices, 3rd Edition, Ed Rosendorf C, pub Springer 2013."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib134","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijcard.2006.11.040","article-title":"Human immunodeficiency virus-infected subjects have no altered myocardial perfusion","volume":"122","author":"Catzin-Kuhlmann","year":"2007","journal-title":"Int J Cardiol."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00259-012-2262-1","article-title":"Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT?","volume":"40","author":"Mariano-Goulart","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1007\/s12350-020-02280-4_bib136","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0002-9149(91)90443-O","article-title":"Prognostic value of thallium-201 perfusion defects in idiopathic dilated cardiomyopathy","volume":"67","author":"Doi","year":"1991","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib137","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0735-1097(02)01726-6","article-title":"Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis","volume":"39","author":"Allman","year":"2002","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib138","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s10741-017-9626-3","article-title":"The role of myocardial viability in contemporary cardiac practice","volume":"22","author":"Jamiel","year":"2017","journal-title":"Heart Fail Rev."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib139","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00259-007-0478-2","article-title":"Quantification of myocardial blood flow with 82Rb dynamic PET imaging","volume":"34","author":"Lortie","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib140","first-page":"1062","article-title":"Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: Comparison with (13)N-ammonia PET","volume":"50","author":"El Fakhri","year":"2009","journal-title":"J Nucl Med Off Publ Soc Nucl Med."},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib141","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1161\/01.CIR.70.4.724","article-title":"Quantification of regional myocardial blood flow in vivo with H215O","volume":"70","author":"Bergmann","year":"1984","journal-title":"Circulation."},{"issue":"8","key":"10.1007\/s12350-020-02280-4_bib142","first-page":"1335","article-title":"Simultaneous in vitro and in vivo validation of nitrogen-13-ammonia for the assessment of regional myocardial blood flow","volume":"31","author":"Bellina","year":"1990","journal-title":"J Nucl Med Off Publ Soc Nucl Med."},{"issue":"12","key":"10.1007\/s12350-020-02280-4_bib143","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/ehjci\/jet068","article-title":"Added prognostic value of myocardial blood flow quantitation in rubidium-82 positron emission tomography imaging","volume":"14","author":"Farhad","year":"2013","journal-title":"Eur Heart J Cardiovasc Imaging."},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib144","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jacc.2011.01.065","article-title":"Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia","volume":"58","author":"Ziadi","year":"2011","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib145","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jacc.2009.02.069","article-title":"Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve","volume":"54","author":"Herzog","year":"2009","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib146","first-page":"941","article-title":"Single photon-emission computed tomography","volume":"17","author":"Holly","year":"2010","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol."},{"issue":"5","key":"10.1007\/s12350-020-02280-4_bib147","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.semnuclmed.2014.06.010","article-title":"Cardiac hot spot imaging with (18)FDG","volume":"44","author":"Jain","year":"2014","journal-title":"Semin Nucl Med."},{"key":"10.1007\/s12350-020-02280-4_bib148","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N Engl J Med."},{"key":"10.1007\/s12350-020-02280-4_bib149","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"J Am Med Assoc."},{"issue":"13","key":"10.1007\/s12350-020-02280-4_bib150","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1097\/QAD.0b013e328306a6c5","article-title":"Subclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort Study","volume":"22","author":"Kingsley","year":"2008","journal-title":"AIDS"},{"issue":"18","key":"10.1007\/s12350-020-02280-4_bib151","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/QAD.0000000000000847","article-title":"Incidence and progression of coronary artery calcium in HIV-infected and HIV-uninfected men","volume":"29","author":"Kingsley","year":"2015","journal-title":"AIDS"},{"issue":"4","key":"10.1007\/s12350-020-02280-4_bib152","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s10554-011-9898-y","article-title":"Progression of coronary artery calcium in men affected by human immunodeficiency virus infection","volume":"28","author":"Guaraldi","year":"2012","journal-title":"Intl J Cardiovasc Imaging."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib153","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.ahj.2012.03.019","article-title":"Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV","volume":"163","author":"Zona","year":"2012","journal-title":"Am Heart J"},{"issue":"7","key":"10.1007\/s12350-020-02280-4_bib154","doi-asserted-by":"crossref","first-page":"458","DOI":"10.7326\/M13-1754","article-title":"Associations between HIV infection and subclinical coronary atherosclerosis","volume":"160","author":"Post","year":"2014","journal-title":"Ann Inter Med."},{"issue":"23","key":"10.1007\/s12350-020-02280-4_bib155","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/eurheartj\/ehy163","article-title":"Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative persons","volume":"39","author":"Tarr","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1007\/s12350-020-02280-4_bib156","doi-asserted-by":"crossref","unstructured":"SCOT-HEART investigators. CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): An open-label, parallel-group, multicentre trial. Lancet Lond Engl 2015;385(9985):2383-2391.","DOI":"10.1016\/S0140-6736(15)60291-4"},{"key":"10.1007\/s12350-020-02280-4_bib157","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.cjca.2018.11.036","article-title":"Noninvasive cardiovascular imaging: Emergence of a powerful tool for early identification of cardiovascular risk in people living with HIV","volume":"35","author":"Ryan","year":"2019","journal-title":"Can J Cardiol"},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib158","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/01.CIR.99.6.763","article-title":"Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography","volume":"99","author":"Nagel","year":"1999","journal-title":"Circulation."},{"issue":"1","key":"10.1007\/s12350-020-02280-4_bib159","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1148\/radiol.2331030463","article-title":"High-dose dobutamine-atropine stress cardiovascular MR imaging after coronary revascularization in patients with wall motion abnormalities at rest","volume":"233","author":"Wahl","year":"2004","journal-title":"Radiology."},{"issue":"6","key":"10.1007\/s12350-020-02280-4_bib160","first-page":"841","article-title":"Myocardial perfusion imaging by cardiac magnetic resonance","volume":"13","author":"Schwitter","year":"2006","journal-title":"J Nucl Cardiol Off Publ Am Soc Nucl Cardiol."},{"issue":"9355","key":"10.1007\/s12350-020-02280-4_bib161","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0140-6736(03)12389-6","article-title":"Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: An imaging study","volume":"361","author":"Wagner","year":"2003","journal-title":"Lancet Lond Engl."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib162","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/hc0202.102123","article-title":"Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: Comparison with positron emission tomography","volume":"105","author":"Klein","year":"2002","journal-title":"Circulation."},{"issue":"3","key":"10.1007\/s12350-020-02280-4_bib163","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1148\/radiol.12120068","article-title":"Coronary vessel wall 3-T MR imaging with time-resolved acquisition of phase-sensitive dual inversion-recovery (TRAPD) technique: Initial results in patients with risk factors for coronary artery disease","volume":"265","author":"Abd-Elmoniem","year":"2012","journal-title":"Radiology."},{"issue":"2","key":"10.1007\/s12350-020-02280-4_bib164","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1871528113666140131151522","article-title":"Rheumatoid arthritis: An autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: Role of cardiovascular magnetic resonance","volume":"13","author":"Mavrogeni","year":"2014","journal-title":"Inflamm Allergy Drug Targets."},{"issue":"17","key":"10.1007\/s12350-020-02280-4_bib165","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.jacc.2009.02.007","article-title":"Cardiovascular magnetic resonance in myocarditis: A JACC White Paper","volume":"53","author":"Friedrich","year":"2009","journal-title":"J Am Coll Cardiol."},{"issue":"11","key":"10.1007\/s12350-020-02280-4_bib166","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.jcmg.2014.04.024","article-title":"Cardiac steatosis and left ventricular dysfunction in HIV-infected patients treated with highly active antiretroviral therapy","volume":"7","author":"Nelson","year":"2014","journal-title":"JACC Cardiovasc Imaging."}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12350-020-02280-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123008395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358123008395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12350-020-02280-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:46:52Z","timestamp":1735573612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358123008395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":166,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1071358123008395"],"URL":"https:\/\/doi.org\/10.1007\/s12350-020-02280-4","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Coronary artery disease in patients with human immunodeficiency virus infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s12350-020-02280-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 American Society of Nuclear Cardiology. Published by ELSEVIER INC. All rights reserved. Published by Mosby, Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}